Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: The PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry

JACC: Cardiovascular Interventions

Volumn 8, Issue 1, 2015, Pages 60-69

  Nazif, Tamim M ^a   Dizon, José M ^a   Hahn, Rebecca T ^a   Xu, Ke ^b   Babaliaros, Vasilis ^c   Douglas, Pamela S ^d   El Chami, Mikhael F ^c   Herrmann, Howard C ^e   Mack, Michael ^f   Makkar, Raj R ^g   Miller, D Craig ^h   Pichard, Augusto ⁱ   Tuzcu, E Murat ^j   Szeto, Wilson Y ^e   Webb, John G ^k   Moses, Jeffrey W ^a   Smith, Craig R ^a   Williams, Mathew R ^a   Leon, Martin B ^a   Kodali, Susheel K ^a  

^a NewYork Presbyterian Hospital   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^e HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^f Baylor Healthcare System   (United States)

^g CEDARS SINAI MEDICAL CENTER   (United States)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ WASHINGTON HOSPITAL CENTER   (United States)

^j LERNER RESEARCH INSTITUTE   (United States)

^k ST PAUL S HOSPITAL   (Canada)

more..

Author keywords

Cardiac conduction; Pacemaker; PARTNER; TAVR; Transcatheter aortic valve replacement

Indexed keywords

AGED; AORTA VALVE PROSTHESIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; CONFIDENCE INTERVAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RIGHT BUNDLE BRANCH BLOCK; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PACEMAKER IMPLANTATION; PRIORITY JOURNAL; PROSTHESIS; RETROSPECTIVE STUDY; RISK; STATISTICAL ANALYSIS; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT INDICATION; TREATMENT OUTCOME; VERY ELDERLY; ADVERSE EFFECTS; AORTA VALVE; AORTIC VALVE STENOSIS; ARRHYTHMIAS, CARDIAC; DEVICES; HEART CATHETERIZATION; HEART PACING; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; KAPLAN MEIER METHOD; PATHOPHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; RISK FACTOR; STATISTICAL MODEL; TIME;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; ARRHYTHMIAS, CARDIAC; CARDIAC CATHETERIZATION; CARDIAC PACING, ARTIFICIAL; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PACEMAKER, ARTIFICIAL; PATIENT READMISSION; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84921417781     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2014.07.022     Document Type: Article

References (41)

1. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607.
2. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-98.
3. Erkapic D, De Rosa S, Kelava A, Lehmann R, Fichtlscherer S, Hohnloser SH. Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovasc Electrophysiol 2012;23:391-7.
4. Khatri PJ, Webb JG, Rodes-Cabau J, et al. Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Intern Med 2013;158:35-46.
5. Jilaihawi H, Chakravarty T, Weiss RE, Fontana GP, Forrester J, Makkar RR. Meta-analysis of complications in aortic valve replacement: comparison of Medtronic-Corevalve, Edwards-Sapien and surgical aortic valve replacement in 8,536 patients. Catheter Cardiovasc Interv 2012;80:128-38.
6. Douglas PS, Waugh RA, Bloomfield G, et al. Implementation of echocardiography core laboratory best practices: a case study of the PARTNER I trial. J Am Soc Echocardiogr 2013;26:348-58, e3.
7. Friedman HS, Zaman Q, Haft JI, Melendez S. Assessment of atrioventricular conduction in aortic valve disease. Br Heart J 1978;40:911-7.
8. Piazza N, de Jaegere P, Schultz C, Becker AE, Serruys PW, Anderson RH. Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv 2008;1:74-81.
9. Fukuda T, Hawley RL, Edwards JE. Lesions of conduction tissue complicating aortic valvular replacement. Chest 1976;69:605-14.
10. Moreno R, Dobarro D, Lopez de Sa E, et al. Cause of complete atrioventricular block after percutaneous aortic valve implantation: insights from a necropsy study. Circulation 2009;120:e29-30.
11. Sinhal A, Altwegg L, Pasupati S, et al. Atrioventricular block after transcatheter balloon expandable aortic valve implantation. J Am Coll Cardiol Intv 2008;1:305-9.
12. Bagur R, Manazzoni JM, Dumont E, et al. Permanent pacemaker implantation following isolated aortic valve replacement in a large cohort of elderly patients with severe aortic stenosis. Heart 2011;97:1687-94.
13. Dawkins S, Hobson AR, Kalra PR, Tang AT, Monro JL, Dawkins KD. Permanent pacemaker implantation after isolated aortic valve replacement: incidence, indications, and predictors. Ann Thorac Surg 2008;85:108-12.
14. Erdogan HB, Kayalar N, Ardal H, et al. Risk factors for requirement of permanent pacemaker implantation after aortic valve replacement. J Cardiac Surg 2006;21:211-5, discussion 216-7.
15. Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014;370:1790-8.
16. Popma JJ, Adams DH, Reardon MJ, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol 2014;63:1972-81.
17. Tzamtzis S, Viquerat J, Yap J, Mullen MJ, Burriesci G. Numerical analysis of the radial force produced by the Medtronic-CoreValve and Edwards-SAPIEN after transcatheter aortic valve implantation (TAVI). Med Eng Phys 2013;35:125-30.
18. Urena M, Webb JG, Tamburino C, et al. Permanent pacemaker implantation following transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function. Circulation 2014;129:1233-43.
19. Goldenberg G, Kusniec J, Kadmon E, et al. Pacemaker implantation after transcatheter aortic valve implantation. Am J Cardiol 2013;112:1632-4.
20. van der Boon RM, Van Mieghem NM, Theuns DA, et al. Pacemaker dependency after transcatheter aortic valve implantation with the self-expanding Medtronic CoreValve System. Int J Cardiol 2013;168:1269-73.
21. Pereira E, Ferreira N, Caeiro D, et al. Transcatheter aortic valve implantation and requirements of pacing over time. Pacing Clin Electrophysiol 2013;36:559-69.
22. De Carlo M, Giannini C, Bedogni F, et al. Safety of a conservative strategy of permanent pacemaker implantation after transcatheter aortic CoreValve implantation. Am Heart J 2012;163:492-9.
23. Ledwoch J, Franke J, Gerckens U, et al. Incidence and predictors of permanent pacemaker implantation following transcatheter aortic valve implantation: analysis from the german transcatheter aortic valve interventions registry. Catheter Cardiovasc Interv 2013;82:E569-77.
24. Bagur R, Rodes-Cabau J, Gurvitch R, et al. Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings. J Am Coll Cardiol Intv 2012;5:540-51.
25. Fraccaro C, Napodano M, Tarantini G. Conduction disorders in the setting of transcatheter aortic valve implantation: a clinical perspective. Catheter Cardiovasc Interv 2013;81:1217-23.
26. Khawaja MZ, Rajani R, Cook A, et al. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). Circulation 2011;123:951-60.
27. Binder RK, Webb JG, Toggweiler S, et al. Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation. J Am Coll Cardiol Intv 2013;6:462-8.
28. Munoz-Garcia AJ, Hernandez-Garcia JM, Jimenez-Navarro MF, et al. Factors predicting and having an impact on the need for a permanent pacemaker after CoreValve prosthesis implantation using the new Accutrak delivery catheter system. J Am Coll Cardiol Intv 2012;5:533-9.
29. Baan J Jr., Yong ZY, Koch KT, et al. Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis. Am Heart J 2010;159:497-503.
30. Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) trial. JAMA 2002;288:3115-23.
31. Sweeney MO, Hellkamp AS, Ellenbogen KA, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003;107:2932-7.
32. Curtis AB, Worley SJ, Adamson PB, et al. Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med 2013;368:1585-93.
33. Buellesfeld L, Stortecky S, Heg D, et al. Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. J Am Coll Cardiol 2012;60:493-501.
34. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53.
35. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80.
36. Tse HF, Yu C, Wong KK, et al. Functional abnormalities in patients with permanent right ventricular pacing: the effect of sites of electrical stimulation. J Am Coll Cardiol 2002;40:1451-8.
37. Hoffmann R, Herpertz R, Lotfipour S, et al. Impact of a new conduction defect after transcatheter aortic valve implantation on left ventricular function. J Am Coll Cardiol Intv 2012;5:1257-63.
38. Nazif TM, Williams MR, Hahn RT, et al. Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. Eur Heart J 2014;35:1599-607.
39. Urena M, Mok M, Serra V, et al. Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve. J Am Coll Cardiol 2012;60:1743-52.
40. Meguro K, Lellouche N, Teiger E. Cardiac resynchronization therapy improved heart failure after left bundle branch block during transcatheter aortic valve implantation. J Invasive Cardiol 2012;24:132-3.
41. Osmancik P, Stros P, Herman D, Kocka V, Paskova E. Cardiac resynchronization therapy implantation following transcatheter aortic valve implantation. Europace 2011;13:290-1.